what is microdose semaglutide Our Clinic’s Microdosing Chart: Real Doses from 200+ Patients (Starting at 0.05 mg) People are 'microdosing' weight-loss drugs.

Single GLP-1 receptor activation (Semaglutide) produces more GI effects than dual GIP/GLP-1 activation (Tirzepatide)

Am J Clin Dermatol 19(1):6777

What makes a peptide company trustworthy in 2026

Immediate medical attention is warranted for: Severe diarrhea (more than 6-8 watery stools daily) Blood or mucus in stools Severe abdominal pain or cramping Severe abdominal pain radiating to the back (possible pancreatitis) Upper right abdominal pain, fever, or yellowing of skin/eyes (possible gallbladder disease) Signs of dehydration (extreme thirst, dark urine, dizziness, confusion) Fever above 101F (38.3C) Unintentional weight loss exceeding expected therapeutic effects Inability to maintain adequate oral fluid intake Healthcare providers should evaluate for potential complications including electrolyte disturbances (hypokalemia, hyponatremia), acute kidney injury from volume depletion, or concurrent gastrointestinal conditions